Bristol Myers Squibb BMY
NYSE BMY
$61.25 +2.42 (+4.11%)
As of: Oct 20, 2026 · 10:57 AM EDT

Bristol Myers Squibb (BMY) Total Debt (2009 - 2026)

Updated

Bristol Myers Squibb's Total Debt came in at $43.12 billion for Q2 2026, down 12.3% from $49.19 billion a year earlier and down 3.0% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Total Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb's Total Debt was $45.11 billion, down 9.1% from FY2024.

  • Total Debt carries a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • Going back by year, Total Debt was $49.65 billion in FY2024 (+24.8%), $39.77 billion in FY2023 (+1.1%), $39.32 billion in FY2022 (-11.7%) and $44.55 billion in FY2021 (-12.1%).
  • The Q2 2026 figure represents the lowest quarterly Total Debt since Q4 2023.
  • Year-over-year, Total Debt has declined for six consecutive quarters, with growth averaging 0.8% over the last eight quarters.
  • The fastest year-over-year change in Total Debt over five years came in Q1 2024 (growth of 47.2%), and the weakest in Q1 2023 (a decline of 15.9%).
  • Business Quant data shows BMY's Total Debt at $44.46 billion (Q1 2026), $45.11 billion (Q4 2025) and $48.98 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,157.23 Bn 1,125.82 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 625.90 Bn 544.43 Bn 17.26 Bn 49.04 Bn
3 AbbVie 509.60 Bn 482.71 Bn 12.70 Bn 70.82 Bn
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 296.36 Bn 260.35 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.03 Bn 234.71 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.15 Bn 190.55 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 193.31 Bn 167.51 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 63.19 Bn
10 Bristol Myers Squibb 124.97 Bn 76.24 Bn 9.25 Bn 43.12 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.12 Bn
Mar 31, 2026 44.46 Bn
Dec 31, 2025 45.11 Bn
Sep 30, 2025 48.98 Bn
Jun 30, 2025 49.19 Bn
Mar 31, 2025 49.71 Bn
Dec 31, 2024 49.65 Bn
Sep 30, 2024 49.75 Bn
Jun 30, 2024 52.39 Bn
Mar 31, 2024 55.68 Bn
Dec 31, 2023 39.77 Bn
Sep 30, 2023 37.60 Bn
Jun 30, 2023 37.68 Bn
Mar 31, 2023 37.83 Bn
Dec 31, 2022 39.32 Bn
Sep 30, 2022 39.10 Bn
Jun 30, 2022 42.06 Bn
Mar 31, 2022 44.97 Bn
Dec 31, 2021 44.55 Bn
Sep 30, 2021 44.74 Bn
API Access

Bristol Myers Squibb Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BMY&period=max&api_key=YOUR_API_KEY